Abstract

To observe the clinical effect of NaoXueShu oral liquid in the treatment of hypertensive cerebral hemorrhage is the objective of the study. 85 neurosurgery inpatients from January 2020 to December 2021 were collected. 85 patients with hypertensive intracerebral hemorrhage were randomized into 43 patients in observation group and 42 patients in control group. The control group was only given conventional treatment and the observation group was given conventional treatment and the NaoXueShu oral liquid, 10 ml each time, using the oral or nasal feeding method, 3 times/d. The changes in the National institutes of health stroke scale score, Glasgow coma scale score, Barthel index and hematoma volume were compared between the two groups at admission and after 2 w and 4 w of treatment, so as to evaluate the effect of NaoXueShu oral liquid in the treatment of hypertensive cerebral hemorrhage. There was no significant difference in National institutes of health stroke scale score, Glasgow coma scale score, Barthel index and hematoma volume between the two groups at admission (p>0.05). At 2 w and 4 w, Glasgow coma scale score and Barthel index have significantly higher (p<0.05) National institutes of health stroke scale scores and hematoma volume of the observation group were significantly lower than the control group (p<0.05). The combination of NaoXueShu oral liquid with conventional treatment can improve the neurological deficit and improve the cure rate.